Pulmonary Hypertension News highlighted the findings of a Temple study that was published in Therapeutic Advances in Respiratory Disease which found antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH